CIRCULATING TUMOR DNA BASED DECISION FOR ADJUVANT TREATMENT IN COLON CANCER STAGE II

NCT04120701 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

1980

Enrollment

OTHER

Sponsor class

Conditions

Patients With Resected Stage II Colon Cancer

Interventions

DRUG: mFOLFOX6

Sponsor

Centre Hospitalier Universitaire Dijon